Harvard Admits Easy Grades Are Too Easy, Cracks Down
Harvard's Faculty of Arts and Sciences approved a move to limit A grades for undergraduates, signaling a major bid to...
Which Is Riskier Index Fund Or Target Date
This intro examines risk profiles for index vs target date funds, offering a clear take on volatility, diversification, and potential drawdowns.
24,893 articles
AI IPO Frenzy Sparks a Pressure Cooker Ready Market
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
Stocks Rise as Investors Shrug Off Renewed Iran Tensions
U.S. stocks moved higher as traders shrugged off renewed fighting in Iran, with gains led by technology and consumer ...
Fidelity Data Shows Record Retirement Savings Surge
In Q1 2026, fidelity data shows record momentum in retirement savings, with strong contributions across 401(k), 403(b...
Introducing 2026 Marketing Leaders: Loan Brands Evolve
A 70-member roster of marketers across mortgage, real estate and housing tech is being honored for driving growth and...
SpaceX Breaks IPO Playbook with Fixed-Price Offering
SpaceX priced its IPO at a fixed $135 per share, aiming to raise roughly $75 billion and valuing the company around $...
Banks Launch Tokenized Deposit Network with Major Lenders
Major U.S. banks are moving to launch a tokenized deposit network in 2027, aiming to bridge traditional payments with...
Should Chip Stocks Dip? Huang’s Clarity Meets Buffett Wisdom
As AI reshapes tech investing, the question lingers: should chip stocks dip? This piece blends Jensen Huang’s long‑te...
Holdings Stock Rallied Thursday as Arm Stock Surged
A strong one-day move lifted ARM stock on Thursday after an upbeat price target and bullish analyst commentary. This ...
The Management Lesson Behind FedEx Freight's Breakaway
FedEx Freight spins off to operate as an independent unit with about $9 billion in revenue, aiming to sharpen its foc...
York Senior Homeowners Included in $2.1B Tax Relief
New York will distribute $2.1 billion in STAR property tax relief to nearly 2.8 million homeowners this summer and fa...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status